Correlation between ¹⁸F-fluoromisonidazole PET and expression of HIF-1α and VEGF in newly diagnosed and recurrent malignant gliomas. (Q55460951)

12 July 2018

title

Correlation between ¹⁸F-fluoromisonidazole PET and expression of HIF-1α and VEGF in newly diagnosed and recurrent malignant gliomas. (English)

1 reference

12 July 2018

author name string

Nobuyuki Kawai

1

1 reference

12 July 2018

Wei Lin

2

1 reference

12 July 2018

Wei-Dong Cao

3

1 reference

12 July 2018

Daisuke Ogawa

4

1 reference

12 July 2018

Keisuke Miyake

5

1 reference

12 July 2018

Reiji Haba

6

1 reference

12 July 2018

Yukito Maeda

7

1 reference

12 July 2018

Yuka Yamamoto

8

1 reference

12 July 2018

Yoshihiro Nishiyama

9

1 reference

12 July 2018

Takashi Tamiya

10

1 reference

12 July 2018

publication date

30 April 2014

1 reference

12 July 2018

number of pages

9

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

12 July 2018

volume

41

1 reference

12 July 2018

issue

10

1 reference

12 July 2018

page(s)

1870-1878

1 reference

12 July 2018

Mechanisms of glioma-associated neovascularization

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

Mechanisms of angiogenesis in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

Angiogenesis and anti-angiogenic molecularly targeted therapies in malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

Complementary but distinct roles for MRI and 18F-fluoromisonidazole PET in the assessment of human glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

Methyl-[11C]-l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

Correlation of L-methyl-11C-methionine (MET) uptake with L-type amino acid transporter 1 in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

Update on anti-angiogenic treatment for malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

Hypoxia assessed by 18F-fluoromisonidazole positron emission tomography in newly diagnosed gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

Fully automated synthesis of [18F]fluoromisonidazole using a conventional [18F]FDG module

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

Identification of 14-3-3 protein isoforms in human astrocytoma by immunohistochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

¹⁸F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

Hypoxia-inducible factor 1alpha/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

Hypoxia-inducible factor 1α expression is a prognostic biomarker in patients with astrocytic tumors associated with necrosis on MR image

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

Angiogenesis of glioma: evaluation of ultrastructural characteristics of microvessels and tubular bodies (Weibel-Palade) in endothelial cells and immunohistochemical findings with VEGF and p53 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

Bevacizumab for the treatment of high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

The pervasive presence of fluctuating oxygenation in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

Relationships between cycling hypoxia, HIF-1, angiogenesis and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

HIF-1-dependent transcriptional activity is required for oxygen-mediated HIF-1alpha degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

Tumour oxygenation assessed by 18F-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2776-9

Induction of HIF-1alpha in response to hypoxia is instantaneous

21 January 2018

1 reference

12 December 2020

HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia

1 reference

12 December 2020

Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients

1 reference

12 December 2020

Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies

1 reference

12 December 2020

Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole

1 reference

12 December 2020

10.1007/S00259-014-2776-9

Identifiers

DOI

1 reference

12 July 2018

Dimensions Publication ID

1005365693

0 references

1 reference

12 July 2018